Infantile hemangioma is the most common benign vascular tumor of infancy. It is absent or presents as a minimal mark at birth, undergoes rapid proliferation during the first 12 months, then enters a slow involution phase between ages 1-7 years. GLUT1 (glucose transporter protein 1) positivity is the pathognomonic immunohistochemical marker of infantile hemangioma and the most important distinguishing feature from congenital hemangiomas and vascular malformations. Superficially located ones present as red-purple, gel-like, well-defined subcutaneous masses. Ultrasonography is the primary diagnostic modality and demonstrates the typical appearance of a high-flow hypervascular solid mass.
Age Range
0-2
Peak Age
0.5
Gender
Female predominant
Prevalence
Common
Infantile hemangioma results from clonal proliferation of endothelial cells mediated by vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). During the proliferative phase (0-12 months), intense neovascularization and endothelial cell proliferation occur — this phase is reflected on ultrasonography as high vascular density and prominent arterial flow. Newly formed vessels demonstrate a low-resistance arterial flow pattern because the capillary bed is not yet mature and arteriovenous shunts are present; this is measured as low resistive index (RI <0.5) on Doppler ultrasonography. GLUT1 protein is normally expressed in placental villous trophoblasts, supporting the hypothesis that infantile hemangioma may be of placental origin. During the proliferative phase, the tumor is intensely perfused and appears as a hypoechoic solid mass on grayscale US — because vascular channels create echo-free structures that reduce overall echogenicity. During the involution phase (1-7 years), endothelial cells undergo apoptosis, vascular channels thrombose and are replaced by fibroadipose tissue — this process is seen on US as increased echogenicity, decreased vascularity, and reduction in mass size. When involution is complete, residual fibroadipose tissue remains and appears as hyperechoic fatty tissue on US.
A hypervascular solid mass with intense arterial and venous flow and low resistive index (RI <0.5) in an infant is the pathognomonic US finding of infantile hemangioma. This high-flow pattern definitively distinguishes from venous malformation (low-flow) and lymphatic malformation (avascular).
In the proliferative phase (0-12 months), infantile hemangioma appears on grayscale US as a well-defined, homogeneous hypoechoic solid mass. The mass has lobulated or oval contours. It is located within subcutaneous fat or between the dermis and subcutaneous tissue. Internal structure is homogeneous, but small echo-free areas (vascular lacunae) may be seen in larger lesions. Compressibility is limited because the tumor is tense due to vascular congestion.
Report Sentence
A well-defined, homogeneous hypoechoic solid mass is seen in the subcutaneous tissue, consistent with the proliferative phase of infantile hemangioma.
On color and power Doppler, infantile hemangioma in the proliferative phase demonstrates marked high-flow hypervascularity — this is a pathognomonic finding. Both arterial and venous flow are intense. On spectral Doppler, low resistive index (RI <0.5) is measured in the arterial waveform, which is a direct indicator of neovascularization and arteriovenous shunt presence. Venous flow is also prominent and may show arterialized venous waveform. During involution, vascularity progressively decreases.
Report Sentence
On color Doppler examination, intense arterial and venous flow with high-flow hypervascularity and low resistive index (RI <0.5) is identified within the lesion, consistent with infantile hemangioma.
The US appearance of infantile hemangioma varies with age and phase. In the early proliferative phase (<6 months), it appears as a homogeneous hypoechoic solid mass. In the late proliferative phase (6-12 months), size reaches maximum and internal heterogeneity may increase. In the involution phase (>12 months), echogenicity progressively increases as fibroadipose replacement begins — fat and fibrous tissue create a hyperechoic appearance. Mass size decreases and margins become irregular. After complete involution, residual hyperechoic fatty tissue may remain.
Report Sentence
Increased echogenicity of the lesion compared to prior examination and decreased vascularity is noted, consistent with the involution phase of infantile hemangioma.
Spectral Doppler may show arterialized venous waveform within the infantile hemangioma — normally flat venous flow becomes pulsatile. This indicates the presence of arteriovenous shunts. Additionally, increased flow velocity and pulsatility are detected in draining veins. This finding has critical diagnostic importance in differentiating high-flow vascular lesions (hemangioma, AVM) from low-flow malformations (venous malformation, lymphatic malformation).
Report Sentence
Spectral Doppler demonstrates arterialized waveform and increased pulsatility in draining veins, supporting the presence of arteriovenous shunting and high-flow vascular lesion diagnosis.
On MRI T2-weighted sequences during the proliferative phase, infantile hemangioma appears as a markedly hyperintense, lobulated mass. Flow voids may be seen within and around the lesion — representing high-flow feeding and draining vessels. Homogeneous T2 hyperintensity reflects the density of vascular structures. In the involution phase, T2 signal intensity decreases and becomes heterogeneous.
Report Sentence
On T2-weighted sequences, a markedly hyperintense lobulated mass is seen with flow voids within and around the lesion indicating vascular structures.
On contrast-enhanced MRI during the proliferative phase, infantile hemangioma shows intense, homogeneous enhancement. This intense enhancement reflects the hypervascular nature of the tumor. In the involution phase, enhancement intensity decreases and becomes heterogeneous — non-enhancing fibroadipose areas emerge. The enhancement pattern is important for monitoring phase transition on follow-up examinations.
Report Sentence
On post-contrast sequences, the lesion demonstrates intense homogeneous enhancement, consistent with the proliferative phase of infantile hemangioma.
After complete involution, residual hyperechoic fatty tissue and fibrous tissue remain at the site of infantile hemangioma. Vascularity has completely disappeared. It may be seen as a small hyperechoic area in the subcutaneous tissue. This appearance indicates that involution is complete and no active vascular tumor remains.
Report Sentence
Residual hyperechoic fibroadipose tissue is seen at the site of previous infantile hemangioma with no vascularity on Doppler — consistent with complete involution.
Criteria
Single, well-defined, round/oval lesion, usually <5cm
Distinct Features
Most common type (60-70%). Generally follows uncomplicated course and 90% involute by age 4. Treatment is usually unnecessary; propranolol is first choice if cosmetic or functional problems arise.
Criteria
Plaque-like, extensive area involvement, following dermatomal or anatomic region
Distinct Features
Larger and higher complication risk. May be associated with PHACE(S) syndrome (posterior fossa anomalies, hemangioma, arterial anomalies, coarctation, eye anomalies). PHACE screening is recommended for facial segmental hemangioma.
Criteria
Subcutaneous or deeper location, minimal or no skin color change on surface
Distinct Features
Clinically diagnosis may be challenging because typical red skin lesion is absent. Requires diagnosis by US/MRI. Involutes later. Intramuscular location may develop growth restriction and functional problems.
Distinguishing Feature
Venous malformation is low-flow (minimal or no flow on Doppler), compressible, fills with Valsalva — hemangioma is high-flow, non-compressible in proliferative phase. GLUT1 is negative in venous malformation.
Distinguishing Feature
Lymphatic malformation is avascular (no flow on Doppler — pathognomonic), multiloculated cystic — hemangioma is solid and intensely vascular. Lymphatic malformation is present at birth, hemangioma shows postnatal proliferation.
Distinguishing Feature
Soft tissue sarcoma typically occurs in children >1 year, shows heterogeneous enhancement, irregular margins and perilesional edema. Hemangioma enhances homogeneously and is well-defined. GLUT1 is negative in sarcoma.
Distinguishing Feature
Congenital hemangioma (RICH/NICH) is present at full size at birth, no postnatal proliferation. GLUT1 is negative. RICH rapidly involutes, NICH does not involute.
Urgency
routineManagement
surveillanceBiopsy
Not NeededFollow-up
6-monthThe vast majority (90%+) of infantile hemangiomas follow an uncomplicated course and involute spontaneously. Treatment indications: life-threatening location (airway, periorbital), functional impairment, ulceration, cosmetic concern. First-line treatment is propranolol (2-3 mg/kg/day). PHACE syndrome screening is recommended for segmental facial hemangiomas. US follow-up is performed at 3-month intervals during the proliferative phase and 6-month intervals during the involution phase.
Most infantile hemangiomas involute spontaneously and require no treatment. Propranolol is the first-line systemic treatment for large, complicated, or cosmetically significant lesions. Lesions threatening airway, vision, or vital structures require urgent intervention.